Hearing Biomarkers in Alzheimer's Disease
阿尔茨海默病的听力生物标志物
基本信息
- 批准号:10740266
- 负责人:
- 金额:$ 81.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-15 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:APP-PS1AccelerationAcoustic StimulationAcousticsAlzheimer disease detectionAlzheimer&aposs DiseaseAlzheimer&aposs disease diagnosisAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAlzheimer&aposs disease related dementiaAlzheimer&aposs disease riskAlzheimer’s disease biomarkerAmyloidAreaAuditoryAuditory Evoked PotentialsAuditory systemBehavioralBiological MarkersBrainCBA/CaJ MouseCell NucleusCognitiveConflict (Psychology)DementiaDetectionDevelopmentDiagnosisEarly DiagnosisElectrophysiology (science)GeneticGenomicsGoalsHearingHearing problemHumanHuman Amyloid Precursor ProteinImpaired cognitionLinkMeasuresMemoryMemory LossMotorMusMutationNerve DegenerationNeurobehavioral ManifestationsNeurodegenerative DisordersNeuronsOutcome MeasurePathologicPersonsPhotic StimulationPresbycusisPrevalencePreventionRoleSensoryStartle ReactionSymptomsSystemTREM2 geneTechniquesTestingTherapeutic EffectTherapeutic InterventionTimeagedauditory pathwaybehavior testcostdementia riskearly detection biomarkersepidemiology studyfamilial Alzheimer diseasefunctional declinehearing impairmenthigh riskimprovedmouse modelmutantneuralnormal agingpreventive interventionprotein aggregationprotein expressionscreeningsensory systemspiral gangliontau Proteinstranscriptome sequencing
项目摘要
Summary
Alzheimer's disease (AD) is a common neurodegenerative disease with progressive memory loss and
cognitive decline. Early detection is critical for prevention and treatment of AD and AD related dementia
(ADRD). It has been estimated that delay of the onset of dementia by even one year would reduce the
prevalence of dementia by 10%. Recently, increasing evidence demonstrates that AD pathological changes
can occur in sensory associated brain areas 5-10 years early before typical AD symptoms present, suggesting
that they could serve as early biomarkers for AD/ADRD detection and diagnosis. Hearing is an important
neural sense. Hearing loss also is a major high-risk factor for dementia. Recent studies demonstrated that
visual and auditory stimulations with gamma oscillation cycles could reduce amyloid-ȕ (Aȕ expression in the
brain and improve memory in AD mice. We hypothesize that hearing has a critical role in AD development and
progression. However, hearing is an understudied field in AD study. Little is known about AD-induced hearing
changes. Previous epidemiological studies demonstrated that AD patients could have hearing loss. However,
since aged persons usually have age-related hearing loss (ARHL), it was hard to distinguish AD-induced
hearing decline from ARHL in those epidemiological studies. The link to AD pathology also could not be
determined and remained unclear. In this project, we will use AD mouse models to identify and characterize
AD-induced functional and pathological changes in the auditory system (Aim 1). Both familial AD (fAD) and
sporadic AD (sAD) mouse models will be used to increase experimental rigor. AD-induced functional changes
in the auditory system will be longitudinally examined and assessed during AD development and progression.
These changes will be linked to Aȕ and Tau protein expressions and genomic changes in the auditory system,
which will be assessed by RNA sequencing. The AD hearing marker, thus, can be unambiguously determined.
In Aim 2, we will use both AD and ARHL mouse models to further distinguish AD-induced hearing decline from
ARHL. We will also define the impact of hearing loss on AD/ADRD development and progression and test
whether ARHL can accelerate/exacerbate AD/ADRD development and progression. These proposed studies
can improve our understanding AD pathology and the role of hearing in AD/ADRD development and
progression. Such information is also critical and required for understanding the underlying mechanism for the
therapeutic effect of acoustic stimulation against AD and further improving treatment and prevention.
总结
阿尔茨海默病(AD)是一种常见的神经退行性疾病,
认知能力下降早期发现是预防和治疗AD及AD相关痴呆的关键
(ADRD).据估计,即使延迟痴呆症发作一年,
痴呆症患病率下降10%。近年来,越来越多的证据表明,AD的病理改变
在典型的AD症状出现之前5-10年,
提示它们可作为AD/ADRD检测和诊断的早期生物标志物。听力是重要的
神经感觉听力损失也是痴呆症的主要高危因素。最近的研究表明,
视觉和听觉刺激与γ振荡周期可以减少淀粉样蛋白-β(AAP 12表达在
改善AD小鼠的记忆力。我们假设听力在AD的发展中起着关键作用,
进展然而,在AD研究中,听觉是一个未被充分研究的领域。关于AD引起的听力知之甚少
变化以往的流行病学研究表明,AD患者可能有听力损失。然而,在这方面,
由于老年人常伴有年龄相关性听力损失(ARHL),
在这些流行病学研究中,与AD病理学的联系也不可能是
确定和仍然不清楚。在这个项目中,我们将使用AD小鼠模型来识别和表征
AD诱导的听觉系统功能和病理变化(目的1)。家族性AD(fAD)和
将使用散发性AD(sAD)小鼠模型来增加实验的严谨性。AD引起的功能变化
将在AD发展和进展期间纵向检查和评估听觉系统中的听觉系统。
这些变化将与听觉系统中的Akt和Tau蛋白表达和基因组变化有关,
这将通过RNA测序来评估。因此,AD听力标记可以被明确地确定。
在目标2中,我们将使用AD和ARHL小鼠模型来进一步区分AD诱导的听力下降和
阿尔。我们还将定义听力损失对AD/ADRD发展和进展的影响,并测试
ARHL是否会加速/加重AD/ADRD的发展和进展。这些研究建议
可以提高我们对AD病理学和听力在AD/ADRD发展中的作用的理解,
进展这些信息对于理解这些疾病的潜在机制也是至关重要的,
声刺激对AD的治疗效果,并进一步改善治疗和预防。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hong-Bo Zhao其他文献
Hong-Bo Zhao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hong-Bo Zhao', 18)}}的其他基金
The effect of noise induced hearing loss on Alzheimer's disease development and progression
噪音引起的听力损失对阿尔茨海默病发生和进展的影响
- 批准号:
10661373 - 财政年份:2023
- 资助金额:
$ 81.83万 - 项目类别:
Connexin Function and Mechanisms of Cx26 Deficiency Induced Hearing Loss
Cx26 缺陷引起的听力损失的连接蛋白功能和机制
- 批准号:
10278375 - 财政年份:2021
- 资助金额:
$ 81.83万 - 项目类别:
Connexin Function and Mechanisms of Cx26 Deficiency Induced Hearing Loss
Cx26 缺陷引起的听力损失的连接蛋白功能和机制
- 批准号:
10793104 - 财政年份:2021
- 资助金额:
$ 81.83万 - 项目类别:
ATP-purinergic mechanisms underlying noise-induced cochlear synaptopathy and hearing loss
噪声引起的耳蜗突触病和听力损失的 ATP 嘌呤能机制
- 批准号:
10093003 - 财政年份:2018
- 资助金额:
$ 81.83万 - 项目类别:
ATP-purinergic mechanisms underlying noise-induced cochlear synaptopathy and hearing loss
噪声引起的耳蜗突触病和听力损失的 ATP 嘌呤能机制
- 批准号:
10756250 - 财政年份:2018
- 资助金额:
$ 81.83万 - 项目类别:
相似海外基金
SHINE: Origin and Evolution of Compressible Fluctuations in the Solar Wind and Their Role in Solar Wind Heating and Acceleration
SHINE:太阳风可压缩脉动的起源和演化及其在太阳风加热和加速中的作用
- 批准号:
2400967 - 财政年份:2024
- 资助金额:
$ 81.83万 - 项目类别:
Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328975 - 财政年份:2024
- 资助金额:
$ 81.83万 - 项目类别:
Continuing Grant
EXCESS: The role of excess topography and peak ground acceleration on earthquake-preconditioning of landslides
过量:过量地形和峰值地面加速度对滑坡地震预处理的作用
- 批准号:
NE/Y000080/1 - 财政年份:2024
- 资助金额:
$ 81.83万 - 项目类别:
Research Grant
Market Entry Acceleration of the Murb Wind Turbine into Remote Telecoms Power
默布风力涡轮机加速进入远程电信电力市场
- 批准号:
10112700 - 财政年份:2024
- 资助金额:
$ 81.83万 - 项目类别:
Collaborative R&D
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328973 - 财政年份:2024
- 资助金额:
$ 81.83万 - 项目类别:
Continuing Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328972 - 财政年份:2024
- 资助金额:
$ 81.83万 - 项目类别:
Continuing Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328974 - 财政年份:2024
- 资助金额:
$ 81.83万 - 项目类别:
Continuing Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332916 - 财政年份:2024
- 资助金额:
$ 81.83万 - 项目类别:
Standard Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332917 - 财政年份:2024
- 资助金额:
$ 81.83万 - 项目类别:
Standard Grant
Radiation GRMHD with Non-Thermal Particle Acceleration: Next-Generation Models of Black Hole Accretion Flows and Jets
具有非热粒子加速的辐射 GRMHD:黑洞吸积流和喷流的下一代模型
- 批准号:
2307983 - 财政年份:2023
- 资助金额:
$ 81.83万 - 项目类别:
Standard Grant